[HTML][HTML] Innate immunity drives pathogenesis of rheumatoid arthritis

MI Edilova, A Akram, AA Abdul-Sater - Biomedical Journal, 2021 - Elsevier
Rheumatoid arthritis (RA) is an autoimmune disease affecting∼ 1% of the general
population. This disease is characterized by persistent articular inflammation and joint …

Where is dopamine and how do immune cells see it?: dopamine-mediated immune cell function in health and disease

SM Matt, PJ Gaskill - Journal of Neuroimmune Pharmacology, 2020 - Springer
Dopamine is well recognized as a neurotransmitter in the brain, and regulates critical
functions in a variety of peripheral systems. Growing research has also shown that …

[HTML][HTML] T cell migration in rheumatoid arthritis

M Mellado, L Martínez-Muñoz, G Cascio… - Frontiers in …, 2015 - frontiersin.org
Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation
in joints, associated with synovial hyperplasia and with bone and cartilage destruction …

Dendritic cells, T cells and their interaction in rheumatoid arthritis

P Wehr, H Purvis, SC Law… - Clinical & Experimental …, 2019 - academic.oup.com
Dendritic cells (DCs) are the key professional antigen-presenting cells which bridge innate
and adaptive immune responses, inducing the priming and differentiation of naive to effector …

[HTML][HTML] The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis

KD Brown, E Claudio, U Siebenlist - Arthritis research & therapy, 2008 - Springer
Nuclear factor-κB (NF-κB) is an inducible transcription factor controlled by two principal
signaling cascades, each activated by a set of signal ligands: the classical/canonical NF-κB …

Dopaminergic regulation of innate immunity: a review

M Pinoli, F Marino, M Cosentino - Journal of neuroimmune pharmacology, 2017 - Springer
Dopamine (DA) is a neurotransmitter in the central nervous system as well as in peripheral
tissues. Emerging evidence however points to DA also as a key transmitter between the …

Immunomodulatory nanoparticles for modulating arthritis flares

WT Johnson, D McBride, M Kerr, A Nguyen… - ACS …, 2023 - ACS Publications
Disease-modifying drugs have improved the treatment for autoimmune joint disorders, such
as rheumatoid arthritis, but inflammatory flares are a common experience. This work reports …

Immunomodulatory effects of berberine on the inflamed joint reveal new therapeutic targets for rheumatoid arthritis management

P Shen, Y Jiao, L Miao, J Chen… - Journal of cellular …, 2020 - Wiley Online Library
Rheumatoid arthritis (RA) is a chronic inflammatory syndrome designated by synovial joint
inflammation leading to cartilage degradation and bone damage as well as progressive …

Development of dendritic cell-based immunotherapy for autoimmunity

CMU Hilkens, JD Isaacs… - International reviews of …, 2010 - Taylor & Francis
Dendritic cells are professional antigen-presenting cells that maintain immune tolerance to
self-antigens by deleting or controlling the pathogenicity of auto-reactive T-cells. Dendritic …

Emerging insights of peptide-based nanotherapeutics for effective management of rheumatoid arthritis

V Pathade, S Nene, S Ratnam, DK Khatri… - Life Sciences, 2023 - Elsevier
Rheumatoid arthritis (RA) is a chronic, prevalent, immune-mediated, inflammatory, joint
disorder affecting millions of people worldwide. Despite current treatment options, many …